Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-4837

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium, showing its molecular framework with calcium ion and water molecules associated in the formula.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph comparing the cumulative incidence percentage over approximately 3.5 years for Atorvastatin versus Placebo groups. The graph shows Atorvastatin with a solid line and Placebo with a dashed line, with Atorvastatin demonstrating a lower cumulative incidence. The hazard ratio (HR=0.64) and p-value (p=0.0005) are noted on the graph.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo. The x-axis represents years from 0 to 5 of follow-up, and the y-axis shows cumulative hazard percentage up to 15%. The Atorvastatin group shows a lower cumulative hazard than placebo, with hazard ratio (HR) 0.63 (0.48-0.83), p=0.001 indicated on the graph.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (in years) for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint (years), and the y-axis represents the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence interval 0.69-0.89 and a P value of 0.0002.*
FDA Label Image

Pdp (68071 4837 9)

Pdp (68071 4837 9)
Label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets, prescription-only. It shows manufacturing by Alkem Laboratories Ltd., Mumbai, and packaging by NuCare Pharmaceuticals, Orange, CA. Includes NDC 68071-4837-9 and warnings to keep out of reach of children and store at controlled temperature 68-77°F.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.